Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

An overview of current and emerging devices for percutaneous left atrial appendage closure

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Chow, DHF, Wong, Y-H, Park, J-W, Lam, Y-Y, De Potter, T, Rodés-Cabau, J, Asmarats, L, Sandri, M, Sideris, E, McCaw, T, Lee, RJ, Sievert, H, Søndergaard, L & De Backer, O 2019, 'An overview of current and emerging devices for percutaneous left atrial appendage closure', Trends in Cardiovascular Medicine, vol. 29, no. 4, pp. 228-236. https://doi.org/10.1016/j.tcm.2018.08.008

APA

Chow, D. H. F., Wong, Y-H., Park, J-W., Lam, Y-Y., De Potter, T., Rodés-Cabau, J., Asmarats, L., Sandri, M., Sideris, E., McCaw, T., Lee, R. J., Sievert, H., Søndergaard, L., & De Backer, O. (2019). An overview of current and emerging devices for percutaneous left atrial appendage closure. Trends in Cardiovascular Medicine, 29(4), 228-236. https://doi.org/10.1016/j.tcm.2018.08.008

CBE

Chow DHF, Wong Y-H, Park J-W, Lam Y-Y, De Potter T, Rodés-Cabau J, Asmarats L, Sandri M, Sideris E, McCaw T, Lee RJ, Sievert H, Søndergaard L, De Backer O. 2019. An overview of current and emerging devices for percutaneous left atrial appendage closure. Trends in Cardiovascular Medicine. 29(4):228-236. https://doi.org/10.1016/j.tcm.2018.08.008

MLA

Vancouver

Author

Chow, Danny H F ; Wong, Yam-Hong ; Park, Jai-Wun ; Lam, Yat-Yin ; De Potter, Tom ; Rodés-Cabau, Josep ; Asmarats, Lluis ; Sandri, Marcus ; Sideris, Eleftherios ; McCaw, Trevor ; Lee, Randall J ; Sievert, Horst ; Søndergaard, Lars ; De Backer, Ole. / An overview of current and emerging devices for percutaneous left atrial appendage closure. In: Trends in Cardiovascular Medicine. 2019 ; Vol. 29, No. 4. pp. 228-236.

Bibtex

@article{1353d91220724fba9cf4a979b632ddb2,
title = "An overview of current and emerging devices for percutaneous left atrial appendage closure",
abstract = "Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.",
keywords = "Animals, Atrial Appendage/physiopathology, Atrial Fibrillation/complications, Cardiac Catheterization/adverse effects, Equipment Design, Humans, Risk Factors, Stroke/diagnosis, Treatment Outcome",
author = "Chow, {Danny H F} and Yam-Hong Wong and Jai-Wun Park and Yat-Yin Lam and {De Potter}, Tom and Josep Rod{\'e}s-Cabau and Lluis Asmarats and Marcus Sandri and Eleftherios Sideris and Trevor McCaw and Lee, {Randall J} and Horst Sievert and Lars S{\o}ndergaard and {De Backer}, Ole",
note = "Copyright {\textcopyright} 2018 Elsevier Inc. All rights reserved.",
year = "2019",
doi = "10.1016/j.tcm.2018.08.008",
language = "English",
volume = "29",
pages = "228--236",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc",
number = "4",

}

RIS

TY - JOUR

T1 - An overview of current and emerging devices for percutaneous left atrial appendage closure

AU - Chow, Danny H F

AU - Wong, Yam-Hong

AU - Park, Jai-Wun

AU - Lam, Yat-Yin

AU - De Potter, Tom

AU - Rodés-Cabau, Josep

AU - Asmarats, Lluis

AU - Sandri, Marcus

AU - Sideris, Eleftherios

AU - McCaw, Trevor

AU - Lee, Randall J

AU - Sievert, Horst

AU - Søndergaard, Lars

AU - De Backer, Ole

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2019

Y1 - 2019

N2 - Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.

AB - Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.

KW - Animals

KW - Atrial Appendage/physiopathology

KW - Atrial Fibrillation/complications

KW - Cardiac Catheterization/adverse effects

KW - Equipment Design

KW - Humans

KW - Risk Factors

KW - Stroke/diagnosis

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85052993421&partnerID=8YFLogxK

U2 - 10.1016/j.tcm.2018.08.008

DO - 10.1016/j.tcm.2018.08.008

M3 - Review

C2 - 30205924

VL - 29

SP - 228

EP - 236

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

IS - 4

ER -

ID: 56524064